Mycotopia Therapies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Mycotopia Therapies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Mycotopia Therapies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $552K, a 51.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $552K +$189K +51.9% Dec 31, 2023 10-K 2024-04-23
Q4 2022 $364K -$363K -49.9% Dec 31, 2022 10-K 2024-04-23
Q4 2021 $726K +$723K +20003% Dec 31, 2021 10-K/A 2023-11-06
Q4 2020 $3.61K Dec 31, 2020 10-K/A 2023-10-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.